A new alternative protein option is being developed for health-conscious markets.

Protein Industries Canada announced a new project today to bring new protein products to Canadians with special nutritional requirements. 

The project involving Enhanced Medical Nutrition (EMN), Acenzia, and Gruppo Nutrition will create alternative plant-based protein options to meet the quality, sensory, and muscle health benefits of whey protein isolate.

Three consumer-ready protein products will be developed: a modular, a ready-to-mix, and a ready-to-drink low-volume liquid protein.

In addition to options that address medical nutrition needs, including those associated with surgery, critical illness, and chronic disease, this project will also create products for the active living and high-performance sports markets. The end products will contain a novel plant-based protein ingredient blend with high functionality and taste quality, reformulated from a past project.

The end products will contain a novel plant-based protein ingredient blend with high functionality and taste quality, reformulated from a past project.

Protein Industries Canada will invest $2.3 million into the $5.4 million project; the remaining cost will be shared between Enhanced Medical Nutrition (EMN), Acenzia, and Gruppo Nutrition.